Rationale: Early-life gastrointestinal microbiome perturbation is associated with immune activation and childhood allergic asthma development. The impact of early-life Lactobacillus rhamnosus GG (LGG)
Early-life host-microbe interactions are critical determinants of immune development, lifelong homeostasis, and disease susceptibility. The PRIMAL trial (Priming Immunity at the Beginning of Life) dem
Adjusted1 incidence rate ratios of changes in the diagnosis and management of postpartum hemorrhage and intrapartum asphyxia in the AMANAT mentoring program in Bihar, India (2015–2017).